Unichem reports 3 consecutive years of losses and no dividends; despite share cancellations, massive dilution risk from 27.6M potential shares from CB/BW overshadows
Continued poor performance: Consolidated revenue of 106.2B KRW, operating loss of 5.7B KRW, net loss of 65.6B KRW. No dividends for three consecutive years due to losses.
Insufficient shareholder returns: No cash or stock dividends for the last three years. No dividend policy or predictability provided.
Weak governance: Only 4 out of 15 core indicators met. Lack of CEO succession policy, risk management policy, and internal control policy.
Shareholder proposal litigation: Minority shareholders (led by Noh Ik-hee) filed shareholder proposals and injunctions, ongoing legal disputes.
Potential dilution risk: Outstanding convertible bonds (6.12B KRW) and bonds with warrants (29.09B KRW) totaling 35.2B KRW, convertible into up to 27.64M shares (30.6% of current shares outstanding).
Positive factor: In 2025-2026, the company completed cancellation of approximately 8.25M treasury shares (total 13.9B KRW), slightly enhancing per-share value.
[AI Comprehensive Analysis]Unichem is exposed to multiple risks including consecutive losses, no dividends, weak governance, and massive potential dilution. While share cancellations are positive, the overhang from convertible instruments limits upside potential, and further capital needs could erode equity value.